P/E ratio for National Healthcare (NHC)
P/E ratio as of April 2024 (TTM): 43.9
According to National Healthcare 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 43.9469. At the end of 2022 the company had a P/E ratio of 41.0.
P/E ratio history for National Healthcare from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 41.0 | 445.4% |
| 2021 | 7.52 | -69.07% |
| 2020 | 24.3 | 25.53% |
| 2019 | 19.4 | -4.16% |
| 2018 | 20.2 | 22.76% |
| 2017 | 16.5 | -27.2% |
| 2016 | 22.6 | 21.74% |
| 2015 | 18.6 | -4.18% |
| 2014 | 19.4 | 45.71% |
| 2013 | 13.3 | 0.22% |
| 2012 | 13.3 | 29.65% |
| 2011 | 10.2 | -28.71% |
| 2010 | 14.4 | -8.47% |
| 2009 | 15.7 | -33.03% |
| 2008 | 23.4 | 57.35% |
| 2007 | 14.9 | -19.57% |
| 2006 | 18.5 | -83.65% |
| 2005 | 113 | 557.82% |
| 2004 | 17.2 | 49.7% |
| 2003 | 11.5 | -6% |
| 2002 | 12.2 | -6.84% |
| 2001 | 13.1 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 The Ensign Group ENSG | 26.3 | -40.27% | 🇺🇸 USA |
 Capital Senior Living
CSU | N/A | N/A | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.